D-Dimer Test Kits

Product catalog summary

Introduction
The document discusses the use of Homogeneous Chemiluminescence Immunoassay (CLIA) for the rapid exclusion of venous thromboembolism (VTE), specifically deep vein thrombosis (DVT) and pulmonary embolism (PE). Accurate and early diagnosis is crucial to prevent complications and reduce mortality risk. Traditional imaging techniques like compression ultrasound and CT pulmonary angiography are used for diagnosis, but due to the low prevalence of confirmed VTE in suspected cases, a non-invasive exclusion test is recommended to avoid unnecessary imaging.

Clinical Usefulness of D-dimer Testing
D-dimer testing has been validated over the past 25 years for diagnosing suspected VTE. It is particularly useful for ruling out VTE in patients with low to medium pre-test probability, as assessed by clinical scores like the Wells Score or Geneva Score. The test is highly sensitive but has low specificity, meaning it should only be used for patients with a non-high probability of VTE.

Assay Specifications

Measuring range: 0.25-20 mg/L
Expected value: <0.5 mg/L
Assay duration: 5 minutes
Sample volume: 50 μL
Sample type: Plasma

System Specifications

Rapid detection with a throughput of 80 tests/hour
Weight: ≤8.5kg
First sample ready in 3 minutes; 7-channel operation
CV < 3%
Touch screen operation with support for LIS/HIS transmission
No magnetic beads or complex liquid paths required
Lyophilized reagents for room temperature storage and transport
Semi-automatic and portable C5000 Dry Micro System

Contact Information
Nanjing Poclight Biotechnology Co., Ltd. provides the test kits and can be contacted via email at [email protected] or through their website at www.poclight.com.

Catalog excerpts

Homogeneous Chemiluminescence Immunoassay ––– A rapid exclusion of venous thromboembolism D-Dimer Test Kits Stroke center Cardiology Department Intensive Care Unit, ICU

Open the catalog to page 1

Introduction Accurate, early diagnosis of VTE (DVT/PE) is critical to prevent complications and risk of death. Imaging techniques are required for a positive diagnosis, including compression ultrasound (CUS) and CT pulmonary angiography (CTPA) for diagnosis of DVT and PE, respectively (1). However, the low prevalence of confirmed VTE in suspected outpatients (20% or less) underscores the importance of a first triage by a non-invasive exclusion test in order to avoid unnecessary imaging (2). Over the past 25 years, the clinical usefulness of D-dimer testing in the diagnosis of patients with suspected...

Open the catalog to page 2

Assay Specification • Measuring range: 0.25-20 mg/L • Assay duration: 5 minutes • Sample type: Plasma [1] Huisman MV, Klok FA. Diagnostic management of acute deep vein thrombosis and pulmonary embolism. J Thromb Haemost 2013;11:412-22. [ 2] Le Gal G, Bounameaux H. Diagnosing pulmonary embolism: running after the decreasing prevalence of cases among suspected patients. J Thromb Haemost. 2004; 2: 1244-6. [3] Righini M, Perrier A, De Moerloose P, Bounameaux H. D-dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost. 2008; 6: 1059-71.

Open the catalog to page 3

Applicable System Poclight Nanjing Poclight Biotechnology Co., Ltd. Address: South Side, 2nd Floor, Building A02, Biopharmaceutical Valley Accelerator (Phase III), No. 142 Huakang Road, Jiangbei New District, Nanjing City, Jiangsu Province, 210000, P. R. China E-mail: [email protected] Website: www.poclight.com

Open the catalog to page 4

D-Dimer Test Kits

D-Dimer Test Kits

Catalog excerpts

All Poclight catalogs and technical brochures